
Regenxbio Inc
NASDAQ:RGNX

Intrinsic Value
The intrinsic value of one
RGNX
stock under the Base Case scenario is
28.13
USD.
Compared to the current market price of 8.97 USD,
Regenxbio Inc
is
Undervalued by 68%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Regenxbio Inc
Fundamental Analysis


Revenue & Expenses Breakdown
Regenxbio Inc
Balance Sheet Decomposition
Regenxbio Inc
Current Assets | 313.2m |
Cash & Short-Term Investments | 267.9m |
Receivables | 33.2m |
Other Current Assets | 12.1m |
Non-Current Assets | 177.7m |
Long-Term Investments | 4.9m |
PP&E | 166.6m |
Other Non-Current Assets | 6.2m |
Free Cash Flow Analysis
Regenxbio Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Regenxbio Inc
Revenue
|
156.7m
USD
|
Cost of Revenue
|
-32.7m
USD
|
Gross Profit
|
124m
USD
|
Operating Expenses
|
-281.4m
USD
|
Operating Income
|
-157.4m
USD
|
Other Expenses
|
-333k
USD
|
Net Income
|
-157.7m
USD
|
RGNX Profitability Score
Profitability Due Diligence
Regenxbio Inc's profitability score is 20/100. The higher the profitability score, the more profitable the company is.

Score
Regenxbio Inc's profitability score is 20/100. The higher the profitability score, the more profitable the company is.
RGNX Solvency Score
Solvency Due Diligence
Regenxbio Inc's solvency score is 54/100. The higher the solvency score, the more solvent the company is.

Score
Regenxbio Inc's solvency score is 54/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
RGNX Price Targets Summary
Regenxbio Inc
According to Wall Street analysts, the average 1-year price target for
RGNX
is 33.58 USD
with a low forecast of 12.12 USD and a high forecast of 54.6 USD.
Dividends
Current shareholder yield for RGNX is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
RGNX
stock under the Base Case scenario is
28.13
USD.
Compared to the current market price of 8.97 USD,
Regenxbio Inc
is
Undervalued by 68%.